Literature DB >> 9157770

Fluoride: the verdict is in, but the controversy lingers.

M Kleerekoper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9157770     DOI： 10.1002/jbmr.5650110503

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  6 in total

Review 1.  The role of SERMs in the management of postmenopausal osteoporosis.

Authors:  J Compston
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

Review 2.  Mechanisms of bone loss and gain in untreated and treated osteoporosis.

Authors:  Juliet Compston
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

3.  Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid induced osteoporosis?

Authors:  W F Lems; J W Jacobs; J W Bijlsma; G J van Veen; H H Houben; H C Haanen; M I Gerrits; H J van Rijn
Journal:  Ann Rheum Dis       Date:  1997-06       Impact factor: 19.103

4.  Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis.

Authors:  W F Lems; W G Jacobs; J W Bijlsma; A Croone; H C Haanen; H H Houben; M I Gerrits; H J van Rijn
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

5.  Differential effects of bacterial toxins on mitogenic actions of sodium fluoride and those of aluminum fluoride in human TE85 osteosarcoma cells.

Authors:  H Hashimoto; K H Lau
Journal:  Mol Cell Biochem       Date:  2001-12       Impact factor: 3.396

Review 6.  Prevention and management of osteoporosis. Current trends and future prospects.

Authors:  J E Compston
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.